Objective: To evaluate the clinical and biochemical features of all black c
hildren confirmed to have galactosaemia from the KwaZulu Natal Province of
South Africa.
Design: Prospective laboratory study. Subjects: These included all black ch
ildren with the presenting clinical features suggestive of the diagnosis of
galactosaemia.
Setting: Department of Chemical Pathology, King Edward VIII Hospital, Durba
n, South Africa.
Method: In each case, urine was screened for the presence of a reducing sub
stance using urinary dipstick followed by thin layer chromatography to esta
blish the presence of galactosaemia. The diagnosis of galacotosaemia was th
en confirmed by analysis of galactose-l phosphate uridyl transferase (GALT)
activity in the erythrocytes using the established Beutler enzyme assay pr
ocedure. Age and sex-matched samples were used as controls for GALT activit
y. The presenting clinical features of each patient on admission were also
recorded.
Interventions: Patients confirmed to have galactosaemia were immediately pl
aced on a galactose free diet.
Results: The age distribution of affected individuals varied from six weeks
to 27 months with 60% of the children being males. The most common present
ing clinical features were jaundice in 77% of the patients, failure to thri
ve 62%, and Cataracts 54%, Four patients had complete absence of GALT activ
ity. Two infants who displayed acute toxicity symptoms and positive urine g
alactose, exhibited normal GALT activity.
Conclusion: GALT deficiency is the most common form of galactosaemia in bla
ck children in the KwaZulu Natal region. Cases of galactokinase or epimeras
e enzyme deficiency appear to be present. Further investigation is required
to establish the occurrence and prevalence of the latter in affected indiv
iduals in this region.